ARIAD Pharma (ARIA) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. BA
6. SPY
7. META
8. HOOD
9. INTC
10. JBLU

Go back to ARIAD Pharma (ARIA) Tops Q4 EPS by 2c

ARIAD Reports 2015 Financial Results, Provides 2016 Product Revenue Guidance and Outlines Company Progress

February 23, 2016 7:35 AM EST

Iclusig Net Product Revenue Guidance for 2016 in the Range of $190 Million to $200 Million

Filing for U.S. Marketing Approval of Brigatinib Expected This Year

Conference Call Scheduled Today at 8:30 a.m. ET

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the fourth quarter and... More